4-enoyl-coenzyme A reductase (NADPH)
RxNorm 15032
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 15032 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: 4-enoyl-coenzyme A reductase (NADPH).
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PT
Designated preferred name (PT):
4-enoyl-CoA reductase (NADPH)
(Atom ID: 10795058)
SY
Synonym (SY):
4-enoyl-coenzyme A reductase (NADPH)
(Atom ID: 10795059)
SY
Synonym (SY):
4-enoyl-coenzyme A reductase (reduced nicotinamide adenine dinucleotide phosphate)
(Atom ID: 10795060)
FN